Clinical Trials Directory

Trials / Sponsors / Noveome Biotherapeutics, formerly Stemnion

Noveome Biotherapeutics, formerly Stemnion

Industry · 13 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Entero
Necrotizing Enterocolitis
Phase 1 / Phase 22024-08-19
TerminatedST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
Persistent Corneal Epithelial Defect
Phase 22022-04-27
CompletedSafety and Tolerability Study of IV ST266 in COVID-19 Subjects
Cytokine Release Syndrome
Phase 12021-05-30
CompletedStudy of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects
Ocular Hypertension
Phase 12019-10-23
CompletedST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects
Persistent Corneal Epithelial Defect
Phase 22019-06-10
CompletedEvaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
Allergic Conjunctivitis
Phase 22016-12-01
CompletedSafety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis
Periodontal Disease
Phase 22016-04-01
CompletedST266 in UV-induced Inflammation
Skin Burns
Phase 22015-03-01
CompletedStudy of ST266 Eye Drops in Treating Dry Eye
Dry Eye Syndrome
Phase 12015-03-01
CompletedTreatment of Human Gingivitis With Amnion-derived Cellular Cytokine Solution (ACCS)
Gingivitis
Phase 12014-03-01
TerminatedStudy of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts
Third Degree Burns, Diabetes
Phase 22012-10-01
CompletedStudy of ST266 Versus Saline in Treating Skin Irritation From Radiation
Radiation-induced Dermatitis
Phase 12012-10-01
TerminatedST266 Versus Standard Care In Treating Partial Thickness Burns
Burns
Phase 1 / Phase 22009-06-01